Nomogram for Predicting Cardiac Death and Heart Transplantation in Arrhythmogenic Right Ventricular Cardiomyopathy
ESC Heart Failure · 2023
DOI: 10.1002/ehf2.14432 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2023. Verfasst von Yiju Luo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China. Hauptthemen laut MEDLINE: Arrhythmogenic Right Ventricular Dysplasia, Nomograms, Heart Transplantation, Death, Sudden, Cardiac. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Programs of Guangdong Province, National Natural Science Foundation of China, Zhongnanshan Medical Foundation of Guangdong Province.
Abstract (Originalsprache)
Aims
In this study, we aimed to develop and validate a competing risk nomogram for predicting cardiac death and heart transplantation (HT) in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC).
Methods
We retrospectively enrolled 149 consecutive patients with ARVC diagnosed at our institution between 2008 and 2022. Cox proportional hazards model was primarily used to identify variables associated with cardiac death and HT. On the basis of these indicators, a competing risk nomogram was developed to predict the 1, 3, and 5 year probabilities of cardiac death and HT. The area under the receiver operating characteristic curve (AUC), Harrell's C-index, and calibration curves were used to evaluate and internally validate the performance of the model. Decision curve analysis was performed to assess the clinical utility of the nomogram.
Result
Of the 149 patients with ARVC, the mean age was 38.77 ± 15.94 years, and most of the patients were men (67.11%, 100/149). Fourteen patients experienced cardiac death and nine underwent HT, during a median follow-up period of 5.8 years (interquartile range, 0.62–5.56 years). Multivariable COX analysis revealed that extent of TWI in the anterior and inferior leads (P = 0.0057), right atrial diameter on transthoracic echocardiography (P = 0.0498), RVEF (P = 0.1036), and LVEF (P < 0.001) all showed statistical significance. The 1-, 3-, and 5-year cumulative incidence of cardiac death and HT were 3.35%, 8.05%, and 11.4%, respectively. The area under the receiver operating characteristic curve of the nomogram for predicting cardiac death and HT at 1, 3, and 5 years after diagnosis of ARVC were 0.860, 0.935, and 0.956. The value of Harrell's C-index is 0.9273 (95% confidence interval 0.8954–0.9590; P < 0.001), indicating that the model had good discriminative ability in internal validation. Decision curve analysis revealed that our model was clinically useful within the entire range of potential treatment thresholds in most cases. The cumulative incidence of the primary outcomes was significantly different between the three risk groups according to nomogram-derived scores (P < 0.001).
Conclusions
On the basis of a retrospective review of patients with ARVC at a single centre, we developed a novel nomogram for predicting the risk of cardiac death and HT after ARVC diagnosis. This competing risk nomogram based on four readily available clinical parameters (right atrial diameter, right and left ventricular ejection fraction, and T-wave inversion) is a potentially useful tool for individualized prognostic assessment in patients with ARVC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
ORCID-Profile: Yiju Luo
Förderung
- Science and Technology Programs of Guangdong Province
- National Natural Science Foundation of China
- Zhongnanshan Medical Foundation of Guangdong Province
Zitieren
APA
Luo, Y., Chen, X., Zhang, Y., Zhang, Q., Liu, F., Luo, G., Wu, S., Xue, Y., Deng, H., Jiang, F., Chen, Z., Liu, Y., & Liao, H. (2023). Nomogram for Predicting Cardiac Death and Heart Transplantation in Arrhythmogenic Right Ventricular Cardiomyopathy. ESC Heart Failure. https://doi.org/10.1002/ehf2.14432
Vancouver
Luo Y, Chen X, Zhang Y, Zhang Q, Liu F, Luo G, et al. Nomogram for Predicting Cardiac Death and Heart Transplantation in Arrhythmogenic Right Ventricular Cardiomyopathy. ESC Heart Failure. 2023. doi:10.1002/ehf2.14432
BibTeX
@article{Luo2023,
author = {Luo, Yiju and Chen, Xin and Zhang, Yuhua and Zhang, Qianhuan and Liu, Fangzhou and Luo, Guanhao and Wu, Shulin and Xue, Yumei and Deng, Hai and Jiang, Fengyu and Chen, Zien and Liu, Yang and Liao, Hongtao},
title = {Nomogram for Predicting Cardiac Death and Heart Transplantation in Arrhythmogenic Right Ventricular Cardiomyopathy},
journal = {ESC Heart Failure},
year = {2023},
doi = {10.1002/ehf2.14432}
}
EUVIMED